This site is intended for healthcare professionals

Farxiga granted priority review in the US for the treatment of patients with chronic kidney disease.- AstraZeneca.

Read time: 1 mins
Last updated:30th Jun 2021
Published:7th Jan 2021
Condition: Chronic Kidney Disease/CKD
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest